Literature DB >> 9674650

Human alpha-adducin gene, blood pressure, and sodium metabolism.

A Kamitani1, Z Y Wong, R Fraser, D L Davies, J M Connor, C J Foy, G C Watt, S B Harrap.   

Abstract

The adducin genes contribute significantly to population variation in rat blood pressure and cell membrane sodium transport. The 460Trp mutation of the human alpha-adducin gene has been associated with hypertension, in particular hypertension sensitive to sodium restriction. We studied the relationship between the 460Trp mutation and population variation in blood pressure and sodium metabolism. From 603 Scottish families, we selected 151 offspring and 224 parents with blood pressures in either the upper (high) or bottom (low) 30% of the population distribution and measured the 460Trp mutation using allele-specific hybridization. In offspring, we also measured exchangeable sodium, plasma volume, and total body water. Plasma levels of components of the renin-angiotensin system, atrial natriuretic peptide, and cellular sodium and transmembrane sodium efflux were also estimated. The overall frequency of the 460Trp mutation was 27.1%. In offspring and parent groups, we found no difference in the genotype or allele frequencies of the 460Trp mutation between subjects with high or low blood pressure. There was no overall association between the alpha-adducin genotypes and blood pressure variation. In offspring, the 460Trp mutation was not associated with any significant differences in body fluid volumes or exchangeable sodium; levels of plasma renin, angiotensin II, aldosterone, or atrial natriuretic peptide; intracellular sodium; or ouabain-sensitive transmembrane sodium efflux. These findings suggest that in our Scottish population, the alpha-adducin 460Trp polymorphism is not related to blood pressure and does not affect whole body or cellular sodium metabolism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674650     DOI: 10.1161/01.hyp.32.1.138

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Cardiac genes and gene databases for cardiovascular disease genetics.

Authors:  K T Tan; A Dempsey; C C Liew
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

2.  Adducin 1 (alpha) Gly460Trp variant is associated with left ventricular geometry in Caucasians and African Americans: The HyperGEN Study.

Authors:  Krati Chauhan; Richard B Devereux; Dc Rao; Ulrich Broeckel; Charles C Gu; Paul Hopkins; Donna K Arnett
Journal:  Int J Mol Epidemiol Genet       Date:  2010-02-26

3.  Association between alpha-adducin gene polymorphism (Gly460Trp) and genetic predisposition to salt sensitivity: a meta-analysis.

Authors:  R Wang; B Zhong; Y Liu; C Wang
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

4.  Alpha-adducin Gly460Trp polymorphism and essential hypertension in Korea.

Authors:  Min-Ho Shin; Eun-Kyung Chung; Hee-Nam Kim; Kyeong-Soo Park; Hae-Sung Nam; Sun-Seog Kweon; Jin Su Choi
Journal:  J Korean Med Sci       Date:  2004-12       Impact factor: 2.153

Review 5.  Genetics of Human Primary Hypertension: Focus on Hormonal Mechanisms.

Authors:  Worapaka Manosroi; Gordon H Williams
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

6.  Gly460Trp polymorphism of the ADD1 gene and essential hypertension in an Indian population: A meta-analysis on hypertension risk.

Authors:  P Ramu; G Umamaheswaran; D G Shewade; R P Swaminathan; J Balachander; C Adithan
Journal:  Indian J Hum Genet       Date:  2010-01

7.  Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension.

Authors:  Li-Na Zhang; Pan-Pan Liu; Lingyan Wang; Fang Yuan; Leiting Xu; Yanfei Xin; Li-Juan Fei; Qi-Long Zhong; Yi Huang; Limin Xu; Ling-Mei Hao; Xu-Jun Qiu; Yanping Le; Meng Ye; Shiwei Duan
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

Review 8.  A Review on Adducin from Functional to Pathological Mechanisms: Future Direction in Cancer.

Authors:  Karrie Mei-Yee Kiang; Gilberto Ka-Kit Leung
Journal:  Biomed Res Int       Date:  2018-05-16       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.